Finanical Statements
Minapharm Pharmaceuticals (MIPH.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 30/06/2026
Published at 9 September 2026 at 09:01Minapharm PharmaceuticalsRelated stock:Minapharm Pharmaceuticals stockAll Minapharm Pharmaceuticals disclosures
Disclosure summary
Company Name: Minapharm Pharmaceuticals
ISIN Code: EGS380G1C011
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 101,816,742
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative loss: 222,221,510
Audit Status: Reviewed
Source: Minapharm Pharmaceuticals
The Financial Statements (2,811 KB)
ISIN Code: EGS380G1C011
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 101,816,742
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative loss: 222,221,510
Audit Status: Reviewed
Source: Minapharm Pharmaceuticals
The Financial Statements (2,811 KB)